The device in question is in direct competition to our product. It currently has a limited FDA approval for adult quadriplegics...all other indications are considered experimental.

The primary problem with that device is that it relies on a percutaneous connection between the diaphragm electrodes and the external transmitter.
This represents a major source of potential infection which can be fatal in a compromised patient.

Our system uses implanted receivers and external antennas to allow the patient's skin to be completely closed and eliminate this risk. This additional equipment also accounts for the cost difference between our product and their device.

Please see the attached flyer, which was recently sent worldwide, which discusses the advantages of our system over this technology.

avery biomedical devices,inc